Market Access Exploring the potential of FHIRs and e-labelling Fast Healthcare Interoperability Resources (FHIRs) allow fast to bu
Market Access Reuters Pharma USA 2023 On March 28th and 29th, industry leaders from across the pharmaceutical ecosystem will descend on Philadelphia for Reuters Pharma USA 2023.
Market Access Reuters Pharma USA 2023 - Day 1 Thanks for joining us here in the City of Brotherly Love for the start of this year's Reuters Pharma USA conference.
Market Access Capping the cost of insulin: altruistic or strategic? The price of insulin has become one of the most talked about issues across the pharma industry.
Market Access The female force behind healthcare innovation Passionate, effective, and forward-thinking female leaders are critical to driving innovation.
Market Access Are we entering a new era of blockbuster weight-loss drugs? Has the industry found a new revenue driver in weight-loss treatments?
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
